Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Palmitic Acid-Rich High Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress.

Chu SG, Villalba JA, Liang X, Xiong K, Tsoyi K, Ith B, Ayaub EA, Tatituri RV, Byers DE, Hsu FF, El-Chemaly S, Kim EY, Shi Y, Rosas IO.

Am J Respir Cell Mol Biol. 2019 Aug 28. doi: 10.1165/rcmb.2018-0324OC. [Epub ahead of print]

PMID:
31461627
2.

Metabolic Changes in Patients With Lymphangioleiomyomatosis Treated With Sirolimus and Hydroxychloroquine.

Tang Y, El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, Bagwe S, Rosas IO, Moss J, Priolo C, Henske EP.

Chest. 2019 Jul 9. pii: S0012-3692(19)31310-8. doi: 10.1016/j.chest.2019.05.038. [Epub ahead of print]

PMID:
31299246
3.

Generalized mosaicism for TSC2 mutation in isolated Lymphangioleiomyomatosis.

Ogorek B, Hamieh L, Lasseter K, Bagwe S, Machado T, Herranz-Ors C, Thorner AR, Nag A, Gulleman P, Giannikou K, Young LR, Pujana MÀ, Darling TN, El-Chemaly S, Moss J, Henske EP, Kwiatkowski DJ.

Eur Respir J. 2019 Jul 4. pii: 1900938. doi: 10.1183/13993003.00938-2019. [Epub ahead of print] No abstract available.

PMID:
31273045
4.

Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients.

Courtwright AM, Lamattina AM, Louis PH, Trindade AJ, Burkett P, Imani J, Shrestha S, Divo M, Keller S, Rosas IO, Goldberg HJ, El-Chemaly S.

Sci Rep. 2019 Jun 21;9(1):9003. doi: 10.1038/s41598-019-45309-6.

5.

Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.

Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ.

Ann Am Thorac Soc. 2019 Sep;16(9):1131-1137. doi: 10.1513/AnnalsATS.201812-869OC.

PMID:
31026404
6.

Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways.

Stump B, Shrestha S, Lamattina AM, Louis PH, Cho W, Perrella MA, Ai X, Rosas IO, Wagner FF, Priolo C, Astin J, El-Chemaly S.

PLoS One. 2019 Apr 9;14(4):e0213831. doi: 10.1371/journal.pone.0213831. eCollection 2019.

7.

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis.

Lamattina AM, Poli S, Kidambi P, Bagwe S, Courtwright A, Louis PH, Shrestha S, Stump B, Goldberg HJ, Thiele EA, Rosas I, Henske EP, El-Chemaly S.

Orphanet J Rare Dis. 2019 Mar 29;14(1):72. doi: 10.1186/s13023-019-1050-4.

8.

Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.

Tsoyi K, Osorio JC, Chu SG, Fernandez IE, De Frias SP, Sholl L, Cui Y, Tellez CS, Siegfried JM, Belinsky SA, Perrella MA, El-Chemaly S, Rosas IO.

Am J Respir Cell Mol Biol. 2019 Jun;60(6):659-666. doi: 10.1165/rcmb.2018-0118OC.

PMID:
30562054
9.

Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Courtwright AM, El-Chemaly S.

Ann Am Thorac Soc. 2019 Feb;16(2):175-181. doi: 10.1513/AnnalsATS.201808-508CME.

PMID:
30540921
10.

An Ethical Framework for the Care of Patients with Prolonged Hospitalization Following Lung Transplantation.

Courtwright AM, Rubin E, Robinson EM, El-Chemaly S, Lamas D, Diamond JM, Goldberg HJ.

HEC Forum. 2019 Mar;31(1):49-62. doi: 10.1007/s10730-018-9364-5.

PMID:
30232675
11.

Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis.

Lamattina AM, Taveira-Dasilva A, Goldberg HJ, Bagwe S, Cui Y, Rosas IO, Moss J, Henske EP, El-Chemaly S.

Chest. 2018 Nov;154(5):1070-1082. doi: 10.1016/j.chest.2018.08.1029. Epub 2018 Aug 23.

PMID:
30144422
12.

[18F]Fluorocholine and [18F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM.

Verwer EE, Kavanagh TR, Mischler WJ, Feng Y, Takahashi K, Wang S, Shoup TM, Neelamegam R, Yang J, Guehl NJ, Ran C, Massefski W, Cui Y, El-Chemaly S, Sadow PM, Oldham WM, Kijewski MF, El Fakhri G, Normandin MD, Priolo C.

Clin Cancer Res. 2018 Dec 1;24(23):5925-5938. doi: 10.1158/1078-0432.CCR-17-3693. Epub 2018 Jul 27.

PMID:
30054282
13.

In-hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization.

Courtwright AM, Rubin E, Robinson EM, Thomasson A, El-Chemaly S, Diamond JM, Goldberg HJ.

Am J Transplant. 2019 Feb;19(2):532-539. doi: 10.1111/ajt.14982. Epub 2018 Jul 23.

PMID:
29940091
14.

The Verge of Collapse.

Weinstock M, Vaidya A, El-Chemaly S, Godleski J, Henske E.

N Engl J Med. 2018 Mar 29;378(13):e18. doi: 10.1056/NEJMimc1708586. No abstract available.

PMID:
29590548
15.

Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation.

El-Chemaly S, O'Brien KJ, Nathan SD, Weinhouse GL, Goldberg HJ, Connors JM, Cui Y, Astor TL, Camp PC Jr, Rosas IO, Lemma M, Speransky V, Merideth MA, Gahl WA, Gochuico BR.

PLoS One. 2018 Mar 16;13(3):e0194193. doi: 10.1371/journal.pone.0194193. eCollection 2018.

16.

The Immunome in Two Inherited Forms of Pulmonary Fibrosis.

El-Chemaly S, Cheung F, Kotliarov Y, O'Brien KJ, Gahl WA, Chen J, Perl SY, Biancotto A, Gochuico BR.

Front Immunol. 2018 Jan 31;9:76. doi: 10.3389/fimmu.2018.00076. eCollection 2018.

17.

The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study.

Cao S, Courtwright AM, Lamattina AM, Guleria I, Burkett P, El-Chemaly S, Goldberg HJ.

J Heart Lung Transplant. 2018 Apr;37(4):531-533. doi: 10.1016/j.healun.2017.11.018. Epub 2017 Nov 22. No abstract available.

18.

Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.

Courtwright AM, Burkett P, Divo M, Keller S, Rosas IO, Trindade A, Mody GN, Singh SK, El-Chemaly S, Camp PC, Goldberg HJ, Mallidi HR.

Ann Thorac Surg. 2018 Feb;105(2):441-447. doi: 10.1016/j.athoracsur.2017.09.033. Epub 2017 Dec 7.

PMID:
29223419
19.

Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis.

Courtwright A, Diamond JM, Wood I, Guleria I, Milford E, El-Chemaly S, Goldberg HJ.

HLA. 2018 Feb;91(2):102-111. doi: 10.1111/tan.13185. Epub 2017 Dec 20.

PMID:
29178607
20.

Emerging biomarkers of lymphangioleiomyomatosis.

Nijmeh J, El-Chemaly S, Henske EP.

Expert Rev Respir Med. 2018 Feb;12(2):95-102. doi: 10.1080/17476348.2018.1409622. Epub 2017 Dec 1. Review.

PMID:
29171770
21.

A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.

Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK.

Chest. 2018 Jan;153(1):94-104. doi: 10.1016/j.chest.2017.09.052. Epub 2017 Oct 31.

22.

Lymphatic Vessels: The Next Frontier in Lung Transplant.

Cui Y, Liu K, Lamattina AM, Visner G, El-Chemaly S.

Ann Am Thorac Soc. 2017 Sep;14(Supplement_3):S226-S232. doi: 10.1513/AnnalsATS.201606-465MG. Review.

23.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700537. doi: 10.1183/13993003.00537-2017. Print 2017 Sep.

24.

Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148.

Tsoyi K, Chu SG, Patino-Jaramillo NG, Wilder J, Villalba J, Doyle-Eisele M, McDonald J, Liu X, El-Chemaly S, Perrella MA, Rosas IO.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):208-215. doi: 10.1165/rcmb.2017-0088OC.

25.

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Lama VN, Belperio JA, Christie JD, El-Chemaly S, Fishbein MC, Gelman AE, Hancock WW, Keshavjee S, Kreisel D, Laubach VE, Looney MR, McDyer JF, Mohanakumar T, Shilling RA, Panoskaltsis-Mortari A, Wilkes DS, Eu JP, Nicolls MR.

JCI Insight. 2017 May 4;2(9). pii: 93121. doi: 10.1172/jci.insight.93121. eCollection 2017 May 4. Review.

26.

Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?

Stump B, Cui Y, Kidambi P, Lamattina AM, El-Chemaly S.

Am J Respir Cell Mol Biol. 2017 Sep;57(3):272-279. doi: 10.1165/rcmb.2016-0290TR. Review.

27.

Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction.

Moniodis A, Townsend K, Rabin A, Aloum O, Stempel J, Burkett P, Camp P, Divo M, El-Chemaly S, Mallidi H, Rosas I, Fuhlbrigge A, Koo S, Goldberg HJ.

J Heart Lung Transplant. 2018 Mar;37(3):340-348. doi: 10.1016/j.healun.2017.03.017. Epub 2017 Mar 24.

PMID:
28431983
28.

Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis.

Courtwright A, El-Chemaly S.

J Heart Lung Transplant. 2017 Aug;36(8):833-834. doi: 10.1016/j.healun.2017.02.020. Epub 2017 Feb 28. No abstract available.

PMID:
28318743
29.

Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis.

Ash SY, Harmouche R, Vallejo DL, Villalba JA, Ostridge K, Gunville R, Come CE, Onieva Onieva J, Ross JC, Hunninghake GM, El-Chemaly SY, Doyle TJ, Nardelli P, Sanchez-Ferrero GV, Goldberg HJ, Rosas IO, San Jose Estepar R, Washko GR.

Respir Res. 2017 Mar 7;18(1):45. doi: 10.1186/s12931-017-0527-8.

30.

Spontaneous Pneumothoraces in Patients with Birt-Hogg-Dubé Syndrome.

Gupta N, Kopras EJ, Henske EP, James LE, El-Chemaly S, Veeraraghavan S, Drake MG, McCormack FX.

Ann Am Thorac Soc. 2017 May;14(5):706-713. doi: 10.1513/AnnalsATS.201611-886OC.

31.

Quantitative computed tomography assessment of bronchiolitis obliterans syndrome after lung transplantation.

Gazourian L, Ash S, Meserve EEK, Diaz A, Estepar RSJ, El-Chemaly SY, Rosas IO, Divo M, Fuhlbrigge AL, Camp PC, Ho VT, Bhatt AS, Goldberg HJ, Sholl LM, Washko GR.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12943. Epub 2017 Apr 12.

32.

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

Cui Y, Steagall WK, Lamattina AM, Pacheco-Rodriguez G, Stylianou M, Kidambi P, Stump B, Golzarri F, Rosas IO, Priolo C, Henske EP, Moss J, El-Chemaly S.

Cancer Res. 2017 Mar 15;77(6):1492-1502. doi: 10.1158/0008-5472.CAN-16-2755. Epub 2017 Feb 15.

33.

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, Peters E, Haughey M, Bienfang D, Jones AM, Julien-Williams P, Cui Y, Villalba JA, Bagwe S, Maurer R, Rosas IO, Moss J, Henske EP.

Chest. 2017 Jun;151(6):1302-1310. doi: 10.1016/j.chest.2017.01.033. Epub 2017 Feb 10.

34.

Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.

Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg HJ.

J Heart Lung Transplant. 2017 Jul;36(7):763-769. doi: 10.1016/j.healun.2016.12.013. Epub 2016 Dec 31.

PMID:
28131664
35.

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis.

Courtwright AM, Goldberg HJ, Henske EP, El-Chemaly S.

Eur Respir Rev. 2017 Jan 17;26(143). pii: 160004. doi: 10.1183/16000617.0004-2016. Print 2017 Jan. Review.

36.

The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.

Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ.

Transplantation. 2017 Sep;101(9):2207-2212. doi: 10.1097/TP.0000000000001494.

PMID:
27893614
37.

Pulmonary Vasculopathy Associated with FIGF Gene Mutation.

Bailey E, Cui Y, Casey A, Stoler JM, Ai X, Ma D, Handin R, Sliz P, Vargas SO, El-Chemaly SY.

Am J Pathol. 2017 Jan;187(1):25-32. doi: 10.1016/j.ajpath.2016.09.008. Epub 2016 Nov 12.

38.

Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation.

Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S.

PLoS One. 2016 Sep 2;11(9):e0162409. doi: 10.1371/journal.pone.0162409. eCollection 2016.

39.

Hermansky-Pudlak Syndrome.

El-Chemaly S, Young LR.

Clin Chest Med. 2016 Sep;37(3):505-11. doi: 10.1016/j.ccm.2016.04.012. Epub 2016 Jun 30. Review.

40.

Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation.

Courtwright AM, Salomon S, Fuhlbrigge A, Divo M, Rosas IO, Camp PC, Mallidi HH, Burkett P, El-Chemaly S, Wolfe DJ, Goldberg HJ.

Clin Transplant. 2016 Sep;30(9):1053-8. doi: 10.1111/ctr.12787. Epub 2016 Jul 17.

PMID:
27312895
41.

Genetics and Idiopathic Interstitial Pneumonias.

Chu SG, El-Chemaly S, Rosas IO.

Semin Respir Crit Care Med. 2016 Jun;37(3):321-30. doi: 10.1055/s-0036-1580694. Epub 2016 May 27. Review.

PMID:
27231858
42.

Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia.

Colby JK, Abdulnour RE, Sham HP, Dalli J, Colas RA, Winkler JW, Hellmann J, Wong B, Cui Y, El-Chemaly S, Petasis NA, Spite M, Serhan CN, Levy BD.

Am J Pathol. 2016 Jul;186(7):1801-1813. doi: 10.1016/j.ajpath.2016.03.011. Epub 2016 May 10.

43.

Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation.

Stout-Delgado HW, Cho SJ, Chu SG, Mitzel DN, Villalba J, El-Chemaly S, Ryter SW, Choi AM, Rosas IO.

Am J Respir Cell Mol Biol. 2016 Aug;55(2):252-63. doi: 10.1165/rcmb.2015-0222OC.

44.

Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, Okajima Y, Dupuis J, Latourelle JC, Cho MH, El-Chemaly S, Coxson HO, Celli BR, Fernandez IE, Zazueta OE, Ross JC, Harmouche R, Estépar RS, Diaz AA, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Budoff MJ, Kinney GL, Hokanson JE, Williams MC, Murchison JT, MacNee W, Hoffmann U, O'Donnell CJ, Launer LJ, Harrris TB, Gudnason V, Silverman EK, O'Connor GT, Washko GR, Rosas IO, Hunninghake GM; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPDGene Investigators.

JAMA. 2016 Feb 16;315(7):672-81. doi: 10.1001/jama.2016.0518.

45.

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

Cui Y, Liu K, Monzon-Medina ME, Padera RF, Wang H, George G, Toprak D, Abdelnour E, D'Agostino E, Goldberg HJ, Perrella MA, Forteza RM, Rosas IO, Visner G, El-Chemaly S.

J Clin Invest. 2015 Nov 2;125(11):4255-68. doi: 10.1172/JCI79693. Epub 2015 Oct 20.

46.

Donor-acquired fat embolism syndrome after lung transplantation.

Jacob S, Courtwright A, El-Chemaly S, Racila E, Divo M, Burkett P, Fuhlbrigge A, Goldberg HJ, Rosas IO, Camp P.

Eur J Cardiothorac Surg. 2016 May;49(5):1344-7. doi: 10.1093/ejcts/ezv347. Epub 2015 Oct 14. Review.

47.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.

48.

Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis.

Patel AS, Song JW, Chu SG, Mizumura K, Osorio JC, Shi Y, El-Chemaly S, Lee CG, Rosas IO, Elias JA, Choi AM, Morse D.

PLoS One. 2015 Mar 18;10(3):e0121246. doi: 10.1371/journal.pone.0121246. eCollection 2015.

49.

The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.

El-Chemaly S, Henske EP.

Expert Rev Respir Med. 2015 Apr;9(2):195-204. doi: 10.1586/17476348.2015.1024663. Epub 2015 Mar 10. Review.

PMID:
25757365
50.

Prevalence and outcome of lung cancer in lung transplant recipients.

Grewal AS, Padera RF, Boukedes S, Divo M, Rosas IO, Camp PC, Fuhlbrigge A, Goldberg H, El-Chemaly S.

Respir Med. 2015 Mar;109(3):427-33. doi: 10.1016/j.rmed.2014.12.013. Epub 2015 Jan 7.

Supplemental Content

Loading ...
Support Center